Edward Marchesi Kua whakaatuhia e ngā tuhinga i tukuna e tētahi kaikōrero ingoakore ki ngā mana whakahaere o Amerika, e whā ngā rōpū rongoā nui o te Hauāuru i utu i ngā pōnahi nui rawa atu ki ngā kaituku Rūhia, e tautoko ana i te hokonga o ngā rongoā mate pukupuku mō ngā hōhipera kāwanatanga. Ko ngā utu, i whakaahuatia he nui rawa , i waenga i te 15% me te 35% , he nui ake i te toharite o te ao, e kore nei e neke ake i te 10%.
Ngā utu nui ki ngā kaihokohoko Rūhia
Ko te kēhi tino rongonui ko Merck , ko tana hoa mahi Rūhia, ko R-Pharm, kua whiwhi i te tata ki te $360 miriona i roto i ngā kirimana kāwanatanga mō te rongoā mate pukupuku a Keytruda . I waenganui i te tau 2020 me te tau 2022, i toa te kamupene i te 2.400 o te tata ki te 5.000 tono tuku , ā, 96% o aua tono i whakawhiwhia kāore i whakahēngia, e whakaū ana i te tata-monopoli mō te rangatira whai mana kua whakaaetia a Alexei Repik.
Te parepare a R-Pharm
I whakakahoretia e te Tumu Whakahaere Matua, a Vasily Ignatyev, ngā whakapae katoa, me te kī he tika ngā whakahokinga moni arumoni , ā, he mārama hoki ngā tukanga tuku tono a te kāwanatanga.
Ko tētahi atu take e pā ana ki a Eli Lilly , i te tau 2022 kua kite i te 34% tāpiri mō ngā hokonga o tana rongoā matatau a Cyramza.
I te tau i mua atu, i whakawhiwhia e te tari hauora o Moscow neke atu i te $5 miriona ngā kirimana ki a Pharmstandard , te kamupene kotahi i tono mō te nuinga o ngā taonga.
Mō AstraZeneca , i hokona tana hua Tagrisso ki ngā whare kāwanatanga i te utu rārangi mana, i runga ake rānei i te utu whaimana, i te iti rawa $3,000 mō ia kete , i roto i te 95% o ngā tono i waenga i te tau 2020 me te 2023, i reira i herea te whai wāhi ki te kaitono kotahi. I whakamahia e te kamupene a Pharmimex , te kaituku i toa i te $114,3 miriona mai i te tata ki te $ 129 miriona i roto i ngā kirimana mō te rongoā Koselugo mai i te tau 2022 ki te 2024, me te kore whakataetae.
Hei whakamutunga, kua whakapaetia a Novartis mō te tinihanga pea i roto i ngā hokohoko a te kāwanatanga mō te rongoā Kisqali , mā roto i ngā kaihokohoko pēnei i a Pharmimex me ngā kamupene e pā ana. I whakaū te kaikorero kua tīmatahia e te kamupene he rangahau ā-roto, engari kāore i te whakapuakina ngā hua ki te marea.
Ngā rangahau me ngā urupare a te kamupene
I ahu mai ngā kōrero i te mahi tahi a te International Consortium of Investigative Journalists (ICIJ), te pae purongo o Ruhia i peia atu, a Proekt, me te maheni Huiterangi Republik. Ahakoa kāore i roto i ngā tuhinga ngā whakawhiti peeke tika, e kī ana ngā kaiwhakapae i āta matapo ngā kamupene matua ki te whakamahinga o ngā tawhē hua hei utu utu ki ngā āpiha hauora.
E whai kawenga ana te U.S. Foreign Corrupt Practices Act mō ngā kamupene matua mēnā ka warewarehia e rātou ngā pūrongo mō te pirau mai i ngā rōpū tuatoru. Heoi, i whakakahore te SEC me te Tari Ture ki te tuku kōrero mō ngā pūrongo i tukuna ki te ICIJ.
He rerekē ngā whakautu a ngā kamupene e whā: Kāore a AstraZeneca me Merck i tuku kōrero, i whakaroa a Eli Lilly i tā rātou whakautu, ā, i tohu a Novartis i tētahi rangahau ā-roto kei te haere tonu.
E whakaatu ana tēnei take i te whakamahinga kino a ngā kamupene nunui o te ao whānui i ngā pūnaha hokohoko tūmatanui pōuriuri, ā, ka pā mai ngā hua kino ki te hauora o ngā tūroro me te whakataetae tika i roto i te rāngai rongoā.